宫颈托对后续妊娠的影响:随机临床试验(ProTWIN)的随访研究
本研究对ProTWIN试验中的813名双胎孕妇在4年后进行随访,评估宫颈托预防早产对后续妊娠结局及母亲生活质量的影响。408名参与者中,宫颈托组与对照组在后续活产率(RR 0.93,95%CI 0.8-1.07)及健康状态指数上无差异。作者认为宫颈托使用对后续妊娠结局和母亲生活质量无长期影响,但产科结局数据因样本量小受限。
要点
- 宫颈托组与对照组后续至少一次活产率无显著差异(RR 0.93,95%CI 0.8-1.07)。
- 首次活产早产(<37周)两组对比为宫颈托组3例 vs 对照组1例(RR 2.57,95%CI 0.28-23.44)。
- 中孕期短宫颈亚组中两组无差异,但分析例数少。
核心结论
- 作者认为宫颈托使用对后续妊娠结局及母亲生活质量无长期影响。
- 产科结局数据因样本量小受限。
研究设计与样本
- ProTWIN试验的随访研究,纳入2009至2012年随机分配至宫颈托组或标准照护组的双胎孕妇。
- 共813名孕妇纳入原试验,408名(50.2%)参与本次随访,其中宫颈托组228名、对照组180名。
- 随访距参与原试验的中位间隔为4.1年(四分位距3.9-7.1年)。
- 采用EQ-5D-3L问卷评估母亲生活质量,并询问后续妊娠情况,计算相对危险度(RR)及95%CI。
- 对中孕期短宫颈(宫颈长度<38 mm)女性进行亚组分析。
主要发现
- 98名(24.0%)参与者在原试验后尝试受孕,其中22名(22.4%)未获得后续妊娠(两组无差异)。
- 7名(7.1%)至少发生一次流产但无活产,67名(68.4%)至少有一次活产(宫颈托组35名 vs 对照组32名;RR 0.93,95%CI 0.8-1.07)。
- 2名女性妊娠结局未知。
- 首次活产早产(<37周)发生于宫颈托组3名 vs 对照组1名(均为单胎;RR 2.57,95%CI 0.28-23.44)。
- 中孕期短宫颈亚组中两组无差异,但分析例数少。
临床怎么用
- 原文未据此给出推荐。
局限性
- 产科结局数据因样本量小受限。
- 中孕期短宫颈亚组分析例数少。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To evaluate the effect of cervical pessary, as a strategy to prevent preterm birth (PTB), on the outcome of subsequent pregnancy and maternal quality of life 4 years after the index twin pregnancy. METHODS: Between 2009 and 2012, the ProTWIN trial randomized women with a multiple pregnancy to pessary use vs standard care for the prevention of PTB. The trial showed no benefit in unselected women with a twin pregnancy, but showed a 60% reduction in poor perinatal outcomes in favor of the pessary group in the subgroup of women with a mid-trimester short cervix (cervical length < 38 mm). All women were invited to participate in a follow-up study 4 years after their participation in the ProTWIN trial. In this follow-up study, maternal quality of life was assessed using the EQ-5D-3L questionnaire and women were asked separate questions about subsequent pregnancies. Results were compared between women who were randomized to the pessary vs the control group in the ProTWIN trial by calculating relative risk (RR) and 95% CI. Subgroup analysis was performed for women with a mid-trimester short cervix (cervical length < 38 mm). RESULTS: Of the 813 women included in the ProTWIN trial, 408 (50.2%) participated in this follow-up study, comprising 228 randomized to the pessary group and 180 to the control group in the original trial. The median interval between participation in the ProTWIN trial and participation in this follow-up study was 4.1 (interquartile range (IQR), 3.9-7.1) years. Ninety-eight (24.0%) participants tried to conceive after their participation in the ProTWIN trial. Of those, 22 (22.4%) women did not have a subsequent pregnancy (no difference between pessary and control groups), seven (7.1%) women had at least one miscarriage but no live birth, and 67 (68.4%) women had at least one live birth (35 in the pessary vs 32 in the control group; RR, 0.93 (95% CI, 0.8-1.07)). In two women, the pregnancy outcome was unknown. Preterm delivery (< 37 weeks of gestation) of the first live birth occurred in three women in the pessary vs one woman in the control group (all singleton; RR, 2.57 (95% CI, 0.28-23.44)). No differences were found between the pessary and control groups in the subgroup of women with mid-trimester short cervix, but the numbers analyzed were small. The median health state index score was 0.95 (IQR, 0.82-0.95), with no difference between the pessary and control groups. CONCLUSION: Our findings suggest that there are no long-term effects of pessary use on the outcome of subsequent pregnancies and maternal quality of life. Data on obstetric outcome were limited due to the small numbers. © 2021 The Authors. Ultrasound in Obstetrics & Gynecology published by John Wiley & Sons Ltd on behalf of International Society of Ultrasound in Obstetrics and Gynecology.
引用
- van Limburg Stirum EVJ, Zegveld SJ, Simons NE, et al. Consequences of cervical pessary for subsequent pregnancy: follow-up of randomized clinical trial (ProTWIN). Ultrasound Obstet Gynecol. 2022. PMID: 34826166. doi:10.1002/uog.24821
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。